To investigate EGFR TKI resistance in HNSCC, we have generated a CAL 27 cell line, CALR, that is resistant to multiple EGFR TKIs (gefitinib, erlotinib, lapatinib and afatinib) (33). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.